SAL(SH:603970) Shang Hai Zheng Quan Bao·2025-08-26 19:50Core Viewpoint - The company has released its 2025 semi-annual report, which includes important financial data and operational updates, and emphasizes the need for investors to review the full report for comprehensive insights [1]. Group 1: Company Overview - The company is identified as Zhongnong Lihua Biotechnology Co., Ltd. with the stock code 603970 [1]. - The board of directors and senior management guarantee the authenticity, accuracy, and completeness of the semi-annual report [1][2]. Group 2: Board Meeting Details - The sixth board meeting was held on August 26, 2025, with all nine directors present, confirming the legality and validity of the meeting [3]. - All resolutions proposed during the board meeting were approved unanimously [4][6]. Group 3: Resolutions Passed - The board approved the proposal regarding the company's 2025 semi-annual report, which is available on the Shanghai Stock Exchange website [4][9]. - The board also approved the use of idle funds for cash management during the first half of 2025, with unanimous support [7][6]. - A report on related party transactions for the first half of 2025 was approved, with certain directors abstaining from the vote [8][10]. - The board approved a risk assessment report concerning the financial company of the supply and marketing group for the first half of 2025 [9][10]. - The board also approved the evaluation opinion on the company's 2025 semi-annual internal audit report [11].